NCI   NIH
Mouse Models of Human Cancers Consortium
Search: 
Site Map
Hematopoietic Cancer Models Site Navigation  
Development of the Hematopoietic Tissue
Classification of Human Hematopoietic Malignancies
Classification of Hematopoietic and Lymphoid Neoplasms in Mice
Molecular Characterization of Human Hematopoietic Malignancies
Genetic Tools for Modeling Leukemia and Lymphoma in the Mouse
Retroviral Insertional Mutagenesis
Cytogenetic Analysis of Murine Leukemias
Expression Profiling of Murine Leukemias
Preclinical Studies
Hematopoietic Protocols
Appendix I
Appendix II
Appendix III
Resources  
1. Hematopoietic Cancer Models Publication (PubMed)  Opens in New Window: 1. Hematopoietic Cancer Models Publication (PubMed)
2. Lymphoma SPOREs  Opens in New Window: 2. Lymphoma SPOREs
3. Hematopoietic Cancer Models (MMHCC)  Opens in New Window: 3. Hematopoietic Cancer Models (MMHCC)
4. Hematopoietic Cancer Models (MMHCC Repository)  Opens in New Window: 4. Hematopoietic Cancer Models (MMHCC Repository)
5. Lymphohematopoietic System Cancer Models (MTB)  Opens in New Window: 5. Lymphohematopoietic System Cancer Models (MTB)
6. Lymphohematopoietic System Cancer Metastases Models (MTB)  Opens in New Window: 6. Lymphohematopoietic System Cancer Metastases Models (MTB)

skip top level navigationHome Mouse Models Experimental Therapeutics Resources MMHCC Communication Bioinformatics Learning Tools  

  Emice  >  Mouse Models  >  Organ Site Models  >  Hematopoietic Cancer Models  >  Development of the Hematopoietic Tissue :

Development of the Hematopoietic Tissue



In the mouse at 7.5 day post-coitum (DPC), before circulation is established between the embryo and the yolk sac, multipotent stem cells capable of lymphoid and myeloid differentiation are found in the Aorta-Gonad-Mesonephros (AGM) region. Isolated AGM cultured in vitro demonstrated that this region is a source of hematopoietic stem cells, which arise autonomously and independently from the yolk sac (Dzierzak and Medvinsky, 1995).

In the human embryo, pluripotent hematopoietic progenitors arise from non-hepatic intraembryonic tissues between 25 and 35 DPC. Nucleated erythroid cells arise in the yolk sac and circulate through the embryo supplying oxygen and nutrients to the developing tissues. As the embryo develops this circulation is replaced by the multilineage hematopoiesis in the fetal liver. Around the 20th week of gestation hematopoiesis is established in the bone marrow. Progressively, hepatic hematopoiesis decreases and the bone marrow becomes the main site for formation of the blood cells. After birth, bone marrow is the only site of blood formation, and liver and spleen may present hematopoietic activity only under pathologic conditions (metaplasia) (Marshall and Thrasher, 2001; Evans, 1997).


Selected References

Dzierzak, E., et al. (1995) Mouse embryonic hematopoiesis. Trends Genet. 11, 359-66.

Evans, T. (1997) Developmental biology of hematopoiesis. Hematol. Oncol. Clin. North Am. 11, 1115-47.

Marshall, C.J., et al (2001) The embryonic origins of human haematopoiesis. Br. J. Haematol. 112, 838-50.


CONTACT US PRIVACY NOTICE DISCLAIMER ACCESSIBILITY APPLICATION SUPPORT  
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov